Xinyi Wang

2.7k total citations · 1 hit paper
89 papers, 2.0k citations indexed

About

Xinyi Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xinyi Wang has authored 89 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 32 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Xinyi Wang's work include Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (13 papers) and RNA modifications and cancer (12 papers). Xinyi Wang is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (13 papers) and RNA modifications and cancer (12 papers). Xinyi Wang collaborates with scholars based in China, United States and Singapore. Xinyi Wang's co-authors include Haiyang Zhang, Shaohua Ge, Guoguang Ying, Yi Ba, Tao Ning, Ting Deng, Ming Bai, Hongli Li, Haiou Yang and Rui Liu and has published in prestigious journals such as Chemical Reviews, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Xinyi Wang

83 papers receiving 2.0k citations

Hit Papers

CAF secreted miR-522 suppresses ferroptosis and promotes ... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyi Wang China 20 1.2k 933 524 420 157 89 2.0k
Shenglin Ma China 25 818 0.7× 518 0.6× 459 0.9× 498 1.2× 128 0.8× 92 1.7k
Daiha Shin South Korea 19 1.4k 1.2× 1.1k 1.2× 1.3k 2.5× 326 0.8× 98 0.6× 31 2.3k
Eloísa Jantus‐Lewintre Spain 29 1.0k 0.9× 923 1.0× 619 1.2× 679 1.6× 250 1.6× 97 2.2k
Yong Xu China 26 1.1k 0.9× 631 0.7× 404 0.8× 461 1.1× 142 0.9× 83 2.1k
Fei Xu China 26 1.1k 0.9× 660 0.7× 467 0.9× 796 1.9× 248 1.6× 133 2.4k
Everett Stone United States 26 1.5k 1.2× 766 0.8× 693 1.3× 261 0.6× 131 0.8× 56 2.4k
William H. St. Clair United States 24 1.0k 0.8× 487 0.5× 565 1.1× 307 0.7× 112 0.7× 60 2.1k
Zhipeng Chen China 28 1.2k 1.0× 492 0.5× 281 0.5× 262 0.6× 282 1.8× 96 2.1k
Jing Peng China 24 1.6k 1.3× 599 0.6× 299 0.6× 732 1.7× 233 1.5× 77 2.5k
Weihua Jiang China 23 1.2k 0.9× 557 0.6× 254 0.5× 351 0.8× 95 0.6× 52 1.9k

Countries citing papers authored by Xinyi Wang

Since Specialization
Citations

This map shows the geographic impact of Xinyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Wang more than expected).

Fields of papers citing papers by Xinyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Wang. The network helps show where Xinyi Wang may publish in the future.

Co-authorship network of co-authors of Xinyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyi Wang. A scholar is included among the top collaborators of Xinyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyi Wang. Xinyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yingluo, Xinyi Wang, Nishta Krishnan, et al.. (2025). Efficacious suppression of primary and metastasized liver tumors by polyIC-loaded lipid nanoparticles. Hepatology.
2.
Jiang, Qin, Wenlong Li, Jie Ye, et al.. (2025). A machine-learning–powered spectral-dominant multimodal soft wearable system for long-term and early-stage diagnosis of plant stresses. Science Advances. 11(26). eadw7279–eadw7279. 5 indexed citations
3.
Wang, Xinyi, Wei Heng Chng, Kevin Tay, et al.. (2025). Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chemical Reviews. 125(21). 10248–10341. 1 indexed citations
4.
Jiang, Qiuping, Xiwen Li, Xinyi Wang, Zhihua Wang, & Guangtao Zhai. (2025). Dataset and Metric for Quality Assessment of HDR Tone Mapping: Detail Visibility, Color Naturalness, and Overall Quality. IEEE Transactions on Multimedia. 27. 4058–4071.
6.
Xu, Jing, et al.. (2024). The impact of ICOSL/ICOS pathway-regulated long non-coding RNAs on liver fibrosis in mice infected with Schistosoma japonicum. Parasites & Vectors. 17(1). 317–317. 1 indexed citations
7.
Jiang, Qiuping, et al.. (2024). Underwater Image Enhancement With Cascaded Contrastive Learning. IEEE Transactions on Multimedia. 27. 1512–1525. 11 indexed citations
8.
Wang, Xinyi, et al.. (2024). NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade. Cellular Signalling. 124. 111405–111405. 4 indexed citations
9.
Chen, Hong, Shan Wang, Yuting Zhang, et al.. (2023). A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. Frontiers in Oncology. 13. 1209707–1209707. 2 indexed citations
10.
Song, Hao, et al.. (2023). Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. BioMed Research International. 2023(1). 4 indexed citations
11.
Wang, Xinyi, et al.. (2023). A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma. Translational Lung Cancer Research. 12(2). 230–246. 16 indexed citations
12.
Yao, Yuanfa, Hanbing Li, Xinyi Wang, et al.. (2023). Novel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells. Genes & Diseases. 10(5). 1787–1790. 1 indexed citations
13.
Ye, Zhihua, et al.. (2022). PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. Cell Death and Disease. 13(7). 633–633. 14 indexed citations
14.
Tao, Sha‐Sha, Peng Wang, Xinyi Wang, et al.. (2022). Causal effect of polyunsaturated fatty acids on bone mineral density and fracture. Frontiers in Nutrition. 9. 1014847–1014847. 5 indexed citations
15.
Zhang, Zheng, Rui Peng, Luyu Zhang, et al.. (2021). RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models. Bioscience Reports. 41(4). 10 indexed citations
16.
Li, Bo, et al.. (2019). Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer. Scientific Reports. 9(1). 11344–11344. 5 indexed citations
17.
Ning, Tao, Haiyang Zhang, Xinyi Wang, et al.. (2017). miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer. Oncology Reports. 38(1). 384–392. 22 indexed citations
18.
Wang, Fei, Keke Yu, Mei Xu, et al.. (2015). Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma. Molecular Cancer. 14(1). 84 indexed citations
19.
Ni, Fang, et al.. (2015). Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells. Oncology Letters. 11(2). 1155–1160. 32 indexed citations
20.
Wang, Xinyi, Quan Zhang, Qing Lin, Yue Zhang, & Zhirong Zhang. (2014). Validated LC–MS/MS method for the simultaneous determination of chlorambucil and its prodrug in mouse plasma and brain, and application to pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 99. 74–78. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026